{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,14]],"date-time":"2024-04-14T00:16:35Z","timestamp":1713053795712},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T00:00:00Z","timestamp":1711584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T00:00:00Z","timestamp":1711584000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Natural Science Research Project for Anhui Universities","award":["2022AH040106","2022AH040106","2022AH040106","2022AH040106"],"award-info":[{"award-number":["2022AH040106","2022AH040106","2022AH040106","2022AH040106"]}]},{"name":"Research fund of Anhui Institute of translational medicine","award":["2021zhyx-C66","2021zhyx-C66","2021zhyx-C66","2021zhyx-C66","2021zhyx-C66"],"award-info":[{"award-number":["2021zhyx-C66","2021zhyx-C66","2021zhyx-C66","2021zhyx-C66","2021zhyx-C66"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Based on liquid-based cytology, we performed an enzyme histochemical staining using acid phosphatase as a marker and termed it ELLBC. The aim of this study was to investigate the value of ELLBC in the diagnosis of bladder cancer.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Fifty patients who were initially diagnosed with suspected bladder cancers (hematuria or bladder irritation symptoms, urinary ultrasound suggestive of bladder mass) at the Second Affiliated Hospital of Anhui Medical University (Anhui, China) from January 2022 to December 2022 were selected as the study subjects, all of whom underwent ELLBC, CC, and histopathology Histopathology was used as the gold standard to calculate the diagnostic efficacy of ELLBC, CC and ELLBC combined with CC in bladder cancer.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Histopathological examination revealed 35 positive cases in 50 patients, including 15 cases of high-grade uroepithelial carcinoma (HGUC) and 20 cases of low-grade uroepithelial carcinoma (LGUC.) The sensitivity of ELLBC was 82.86%, the specificity was 93.33%, the positive predictive value (PPV) was 96.67%, the negative predictive value (NPV) was 70.00%, and the accuracy was 86.00%; CC had a sensitivity of 37.14%, specificity of 80.00%, PPV of 81.25%, NPV of 35.29%, and accuracy of 50%; ELLBC combined with CC had a sensitivity of 88.57%, specificity of 73.33%, PPV of 88.57%, NPV of 73.33%, and accuracy of 84.00%. The sensitivity and specificity of ELLBC were higher than that of CC, and the difference was statistically significant  (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05), ELLBC combined with CC achieved higher sensitivity, but the diagnostic accuracy decreased. For clinical staging, the diagnostic accuracy was 86.36% for ELLBC and 40.91% for CC in patients in Stage I, and 90.91% for ELLBC and 36.36% for CC in patients in Stage II.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>ELLBC has high clinical application value for the diagnosis of bladder cancer and can provide new options and methods for the early screening of bladder cancer.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00432-024-05613-9","type":"journal-article","created":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T15:02:09Z","timestamp":1711638129000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Enzyme-labeled liquid-based cytology (ELLBC): a new noninvasive diagnostic method for bladder cancers"],"prefix":"10.1007","volume":"150","author":[{"given":"Chao","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruilong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongliu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,3,28]]},"reference":[{"key":"5613_CR1","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","volume":"18","author":"M Babjuk","year":"2022","unstructured":"Babjuk M, Burger M, Capoun O et al (2022) European association of urology guidelines on non-muscle-invasive bladder cancer (Ta, T1, and carcinoma in situ) [J]. Eur Urol 18:75\u201394","journal-title":"Eur Urol"},{"key":"5613_CR2","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/PAP.0000000000000118","volume":"23","author":"GA Barkan","year":"2016","unstructured":"Barkan GA, Wojcik EM, Nayar R et al (2016) The paris system for reporting urinary cytology: the quest to develop a standardized terminology [J]. Adv Anatom Pathol 23:193\u2013201","journal-title":"Adv Anatom Pathol"},{"key":"5613_CR3","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.3390\/ijms18112423","volume":"18","author":"C Chan","year":"2017","unstructured":"Chan C, Law B, So W et al (2017) Novel strategies on personalized medicine for breast cancer treatment: an update [J]. Int J Mol Sci 18:2423","journal-title":"Int J Mol Sci"},{"key":"5613_CR4","doi-asserted-by":"publisher","first-page":"922","DOI":"10.7326\/M15-0997","volume":"163","author":"R Chou","year":"2015","unstructured":"Chou R, Gore JL, Buckley D et al (2015) Urinary biomarkers for diagnosis of bladder cancer: a systematic review and meta-analysis [J]. Ann Internal Med 163:922\u2013931","journal-title":"Ann Internal Med"},{"key":"5613_CR5","doi-asserted-by":"crossref","unstructured":"Costantini M, Gallo G, Attolini G (2021) Urinary biomarkers in bladder cancer. [A]. In: \u89c1: Urinary Biomarkers, Methods in Molecular Biology [M], pp 121\u2013131","DOI":"10.1007\/978-1-0716-1354-2_11"},{"key":"5613_CR6","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1111\/cyt.13040","volume":"32","author":"D Goutas","year":"2021","unstructured":"Goutas D, Savvidou K, Vrettou K et al (2021) Comparison of conventional and liquid-based cytology using the paris system for reporting urinary cytology [J]. Cytopathology 32:795\u2013801","journal-title":"Cytopathology"},{"key":"5613_CR7","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/170578b0","volume":"170","author":"E Grogg","year":"1952","unstructured":"Grogg E, Pearse AGE (1952) Coupling azo dye methods for histochemical demonstration of alkaline phosphatase.[J]. Nature 170:578\u2013579","journal-title":"Nature"},{"key":"5613_CR8","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.eururo.2019.04.035","volume":"76","author":"B Konety","year":"2019","unstructured":"Konety B, Shore N, Kader AK et al (2019) Evaluation of cxbladder and adjudication of atypical cytology and equivocal cystoscopy[J]. Eur Urol 76:238\u2013243","journal-title":"Eur Urol"},{"key":"5613_CR9","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.urology.2017.07.016","volume":"108","author":"K Koo","year":"2017","unstructured":"Koo K, Zubkoff L, Sirovich BE et al (2017) The burden of cystoscopic bladder cancer surveillance: anxiety, discomfort, and patient preferences for decision making [J]. Urology 108:122\u2013128","journal-title":"Urology"},{"key":"5613_CR10","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.eururo.2015.10.024","volume":"69","author":"J Leal","year":"2016","unstructured":"Leal J, Luengo-Fernandez R, Sullivan R et al (2016) Economic burden of bladder cancer across the european union [J]. Eur Urol 69:438\u2013447","journal-title":"Eur Urol"},{"issue":"12","key":"5613_CR11","doi-asserted-by":"publisher","first-page":"6446","DOI":"10.21037\/jtd.2018.11.64","volume":"10","author":"YH Li","year":"2018","unstructured":"Li YH, Wang Y, Chen XX, Liang B, Qiu XS, Wang EH, Wu GP (2018) Diagnostic value of acid phosphatases (ACP) in differentiating reactive mesothelial cells from cancer cells in the body fluid effusions. J Thorac Dis 10(12):6446\u20136451","journal-title":"J Thorac Dis"},{"key":"5613_CR12","first-page":"251","volume":"10","author":"M Miyake","year":"2018","unstructured":"Miyake M, Owari T, Hori S et al (2018) Emerging biomarkers for the diagnosis and monitoring of urothelial carcinoma [J]. Res Rep Urol 10:251\u2013261","journal-title":"Res Rep Urol"},{"key":"5613_CR13","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/bju.15368","volume":"128","author":"M Miyake","year":"2021","unstructured":"Miyake M, Nakai Y, Nishimura N et al (2021) Hexylaminolevulinate-mediated fluorescent urine cytology with a novel automated detection technology for screening and surveillance of bladder cancer[J]. BJU Int 128:244\u2013253","journal-title":"BJU Int"},{"key":"5613_CR14","doi-asserted-by":"crossref","unstructured":"Ng K, Stenzl A, Sharma A, et al (2021) Urinary biomarkers in bladder cancer: a review of the current landscape and future directions [J]. Urol Oncol Semin Orig Investig:41\u201351","DOI":"10.1016\/j.urolonc.2020.08.016"},{"key":"5613_CR15","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1007\/s00784-017-2047-9","volume":"21","author":"TW Remmerbach","year":"2017","unstructured":"Remmerbach TW, Pomjanski N, Bauer U et al (2017) Liquid-based versus conventional cytology of oral brush biopsies: a split-sample pilot study[J]. Clinical Oral Investigations 21:2493\u20132498","journal-title":"Clinical Oral Investigations"},{"key":"5613_CR16","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.eururo.2022.11.023","volume":"84","author":"EJ Schafer","year":"2023","unstructured":"Schafer EJ, Jemal A, Wiese D et al (2023) Disparities and trends in genitourinary cancer incidence and mortality in the USA[J]. Eur Urol 84:117\u2013126","journal-title":"Eur Urol"},{"key":"5613_CR17","doi-asserted-by":"publisher","DOI":"10.1007\/s12282-010-0215-8","author":"K Seki","year":"2011","unstructured":"Seki K, Tsuda H, Iwamoto E et al (2011) Histopathological effect of radiofrequency ablation therapy for primary breast cancer, with special reference to changes in cancer cells and stromal structure and a comparison with enzyme histochemistry[J]. Breast Cancer. https:\/\/doi.org\/10.1007\/s12282-010-0215-8","journal-title":"Breast Cancer"},{"key":"5613_CR18","unstructured":"Siegel R, Miller K, Sandeep N, et al (2023) Cancer statistics [J]"},{"key":"5613_CR19","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/cncr.21425","volume":"108","author":"BJ Sweeney","year":"2005","unstructured":"Sweeney BJ, Haq Z, Happel JF et al (2005) Comparison of the effectiveness of two liquid-based Papanicolaou systems in the handling of adverse limiting factors, such as excessive blood [J]. Cancer 108:27\u201331","journal-title":"Cancer"},{"key":"5613_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/s11934-018-0857-1","author":"W Tabayoyong","year":"2018","unstructured":"Tabayoyong W, Kamat AM (2018) Current use and promise of urinary markers for urothelial cancer [J]. Curr Urol Rep. https:\/\/doi.org\/10.1007\/s11934-018-0857-1","journal-title":"Curr Urol Rep"},{"key":"5613_CR21","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/bju.14459","volume":"123","author":"WS Tan","year":"2019","unstructured":"Tan WS, Sarpong R, Khetrapal P et al (2019) Does urinary cytology have a role in haematuria investigations[J]. BJU Int 123:74\u201381","journal-title":"BJU Int"},{"issue":"6","key":"5613_CR22","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.3390\/cells10061501","volume":"10","author":"Y Tsutsumi","year":"2021","unstructured":"Tsutsumi Y (2021) Pitfalls and caveats in applying chromogenic immunostaining to histopathological diagnosis. Cells 10(6):1501","journal-title":"Cells"},{"key":"5613_CR23","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2018.8326","author":"X Xu","year":"2018","unstructured":"Xu X, Li P, Fu D et al (2018) Combined use of urinary Survivin detection and liquid-based cytology for the early diagnosis of bladder urothelial carcinoma [J]. Oncol Lett. https:\/\/doi.org\/10.3892\/ol.2018.8326","journal-title":"Oncol Lett"},{"key":"5613_CR24","first-page":"66e25","volume":"33","author":"FA Yafi","year":"2015","unstructured":"Yafi FA, Brimo F, Steinberg J et al (2015) Prospective analysis of sensitivity and specificity of urinary cytology and other urinary biomarkers for bladder cancer [J]. Urol Oncol Semin Orig Investig 33:66e25-66e31","journal-title":"Urol Oncol Semin Orig Investig"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-024-05613-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-024-05613-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-024-05613-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,13]],"date-time":"2024-04-13T11:13:06Z","timestamp":1713006786000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-024-05613-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,28]]},"references-count":24,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,3]]}},"alternative-id":["5613"],"URL":"https:\/\/doi.org\/10.1007\/s00432-024-05613-9","relation":{},"ISSN":["1432-1335"],"issn-type":[{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,28]]},"assertion":[{"value":"1 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants are in a cooperative relationship with each other. The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was conducted strictly in accordance with all applicable laws. The Second Hospital of Anhui Medical University (YX2022-064) has granted us ethical approval. All patients signed the necessary informed consent forms and consented to take part in our investigation.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All patients signed the relevant paper informed consent form.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"169"}}